Trial site
Azienda Ospedaliera Ospedale Niguarda Ca' Granda
- 14running trials
- 6closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Aortic stenosis2 trials
- Chronic lymphocytic leukaemia2 trials
- Colorectal cancer2 trials
- Heart failure2 trials
- Liver and biliary tract cancer2 trials
- Stroke2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Brain aneurysm1 trial
- Burkitt lymphoma1 trial
- Childhood cancers1 trial
- Crohn's disease1 trial
- and 3 more
- Phase
- Phase 27 trials
- Phase 36 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting7 trials
- Active, not recruiting6 trials
- Completed6 trials
- Not yet recruiting1 trial
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto2 trials
- Medtronic2 trials
- Novartis Pharmaceuticals2 trials
- Curium US LLC1 trial
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 trial
- and 12 more
Running trials
Not yet recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Active, not recruiting
Recruiting
Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3)
Active, not recruiting
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
Active, not recruiting
A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
Active, not recruiting
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
Active, not recruiting
Active, not recruiting
Personalized Therapy Study - HFRS (TriageHF) Post Approval Study
Active, not recruiting
Active, not recruiting
Personalized Therapy Study - Attain Stability Quad Post-Approval Study
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Aortic stenosis1 recruiting
- Brain aneurysm1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Crohn's disease1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Regorafenib-pembrolizumab vs. TACE/TARE in intermediate-stage HCC beyond up-to-7.
Completed
Completed
Completed
Completed
FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026